glp-1 agonists with cardiovascular benefit receptor are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Effects of GLP-1 receptor agonists

Ogeil RP, Chakraborty SP, Young AC, Lubman DI

Patients with diverticulitis sometimes report theres so much of it that it looks like the toilet bowl is filled with blood

Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman M, Miyamura T & Brchot C (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

In fact, most experts have said that some people lose weight at a slow rate because of low metabolism and lack of L-Carnitine in their diet

GH also activates the MAPK/ERK pathway through Shc recruitment, the PI3K/AKT/mTOR pathway through IRS adaptors, and Src family kinases through a JAK2-independent branch